Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Membr Biol ; 245(11): 675-81, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22772441

ABSTRACT

The chronic mild stress (CMS) protocol is widely used to evoke depression-like behaviors in the laboratory. Some animals exposed to CMS are resistant to the development of anhedonia, whereas the remaining are responsive, CMS-resilient and CMS-sensitive, respectively. The aim of this study was to examine the effects of chronic stress on oxidative parameters in the rat brain. The consumption of sweet food, protein and lipid oxidation levels and superoxide dismutase and catalase activities in the rat hippocampus, cortex and cerebellum were assessed. We found a significant increase in protein peroxidation (hippocampus and cortex), a significant increase in catalase activity (cortex, hippocampus and cerebellum) and a decrease in superoxide dismutase activity (cortex, hippocampus and cerebellum) in the CMS-sensitive group compared to the CMS-resilient group and normal controls as well as an increase in lipid peroxidation (cerebellum) in the CMS-sensitive and CMS-resilient groups compared to normal controls. However, there was no significant difference in protein peroxidation (cerebellum) and lipid peroxidation (cortex and hippocampus) among the three groups. In conclusion, our results indicate that the segregation into CMS-sensitive and -resilient groups based on sucrose intake is paralleled by significant differences in oxidative parameters. CMS induces oxidative damage and alterations in the activity of antioxidants which may lead to increased oxidative damage, irrespective of the anhedonia-like status of the stressed animals.


Subject(s)
Brain/metabolism , Depression/metabolism , Stress, Psychological , Anhedonia , Animals , Antioxidants/metabolism , Male , Oxidation-Reduction , Oxidative Stress , Rats , Sucrose/metabolism
2.
J Neurosci Res ; 88(12): 2747-54, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20648659

ABSTRACT

Urokinase-type plasminogen activator receptor (uPAR) is a glycosyl phosphatidylinositol-anchored protein involved in cell adhesion, proliferation, differentiation, migration, invasion, and tissue repair and remodeling. Our aim was to investigate uPAR expression in the frontal cortex of patients with intractable frontal lobe epilepsy and to explore the possible role of uPAR in intractable epilepsy. Tissue samples were obtained from the frontal cortex of 25 patients who had undergone surgery for intractable epilepsy and 15 histologically normal frontal cortex tissues from patients with orbital frontal lobe severe contusion (the control group). The frontal cortex expression of uPAR was studied by Western blot and immnohistochemistry. Double immunofluorescence was used to determine the expression of uPAR in astrocytes, microglia, and neurons. The normal frontal cortex uPAR protein level was shown to be low. In the brain tissue of patients with intractable epilepsy, the expression of uPAR protein increased dramatically. Based on the results of double immunofluorescence, many uPAR-positive cells are colocalized with the cell soma of NeuN-positive neurons, whereas only a few GFAP- and CD11b-positive cells colocalized with uPAR staining. These findings provide new information pertaining to the epileptogenesis of intractable epilepsy and suggest that increased expression of uPAR in human brain may be associated with human intractable epilepsy.


Subject(s)
Epilepsy/genetics , Epilepsy/metabolism , Frontal Lobe/metabolism , Receptors, Urokinase Plasminogen Activator/genetics , Adolescent , Adult , Biomarkers/metabolism , Brain Chemistry/genetics , Child , Child, Preschool , Epilepsy/pathology , Female , Frontal Lobe/pathology , Frontal Lobe/surgery , Humans , Male , Receptors, Urokinase Plasminogen Activator/biosynthesis , Young Adult
3.
Neurosci Lett ; 430(3): 187-90, 2008 Jan 17.
Article in English | MEDLINE | ID: mdl-18180108

ABSTRACT

The clinic treatment of epilepsy with epileptic foci overlapped with eloquent cortex is not satisfactory. In this study we investigated the direct effects of low- and high-frequency electric cortical stimulation (ECS) on ferric chloride-induced seizures in the experimental rats. Results showed that spontaneous seizures were observed in all rats during the EEG recording after the intracortical injection of ferric chloride solution into left sensorimotor cortex. One-hertz or 100-Hz ECS with 0.3 ms duration and 0.1 mA amplitude square pulses in 1h on the cortical lesioned area significantly decreased the number of seizures compared with that of the non-stimulation control group. The mean duration time of seizures in 1-Hz or 100-Hz groups was apparently shorter than that in the control group. In brief, this study showed that both low- and high-frequency ECS suppressed the seizures induced by ferric chloride in rats, indicating their potential treatment effects on epilepsy in clinic.


Subject(s)
Cerebral Cortex/physiopathology , Electric Stimulation Therapy/methods , Epilepsy/physiopathology , Epilepsy/therapy , Action Potentials/drug effects , Action Potentials/physiology , Animals , Cerebral Cortex/drug effects , Chlorides , Convulsants , Electroencephalography , Epilepsy/chemically induced , Ferric Compounds , Male , Motor Cortex/drug effects , Motor Cortex/physiopathology , Neural Inhibition/drug effects , Neural Inhibition/physiology , Rats , Rats, Sprague-Dawley , Somatosensory Cortex/drug effects , Somatosensory Cortex/physiopathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL